SpringerLink
Log in

Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background and Aim

Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) is a novel fibrosis marker. We examined the ability of M2BPGi to predict liver fibrosis in patients with biliary atresia.

Methods

Sixty-four patients who underwent living donor liver transplantation (LDLT) were included [median age, 1.1 years (range 0.4–16.0), male 16 patients (25.0 %)]. We examined M2BPGi levels in serum obtained the day before LDLT, and we compared the value of the preoperative M2BPGi levels with the histological evaluation of fibrosis using the METAVIR fibrosis score. Subsequently, we assessed the ability of M2BPGi levels to predict fibrosis.

Results

The median M2BPGi level in patients with BA was 6.02 (range, 0.36–20.0), and 0, 1, 1, 11, and 51 patients had METAVIR fibrosis scores of F0, F1, F2, F3, and F4, respectively. In patients with F4 fibrosis, the median M2BPGi level was 6.88 (quartile; 5.235, 12.10), significantly higher than that in patients with F3 fibrosis who had a median level of 2.42 (quartile; 1.93, 2.895, p < 0.01). Area under the curve analysis for the ability of M2BPGi level to predict grade fibrosis was 0.917, with a specificity and sensitivity of 0.923 and 0.941, respectively. In comparison with other fibrosis markers such as hyaluronic acid, procollagen-III-peptide, type IV collagen 7 s, and aspartate aminotransferase platelet ratio index, M2BPGi showed the strongest ability to predict grade F4 fibrosis.

Conclusion

M2BPGi is a novel fibrosis marker for evaluating the status of the liver in patients with BA, especially when predicting grade F4 fibrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

APRI:

Aspartate aminotransferase platelet ratio index

AUC:

Area under the curve

BA:

Biliary atresia

LB:

Liver biopsy

LDLT:

Living donor liver transplantation

P-III-P:

Procollagen-3-peptide

ROC:

Receiver operating characteristics

M2BPGi:

Mac-2 binding protein glycosylation isomer

References

  1. Hackl C, Schlitt HJ, Melter M, et al. Current developments in pediatric liver transplantation. World J Hepatol. 2015;7:1509–20.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Nio M, Wada M, Sasaki H, et al. Effects of age at Kasai portoenterostomy on the surgical outcome: a review of the literature. Surg Today. 2015;45:813–8.

    Article  PubMed  Google Scholar 

  3. Lykavieris P, Chardot C, Sokhn M, et al. Outcome in adulthood of biliary atresia: a study of 63 patients who survived for over 20 years with their native liver. Hepatology. 2005;41:366–71.

    Article  PubMed  Google Scholar 

  4. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. (London, England) 2009; 374:1704–13.

  5. Mizuta K, Urahashi T, Ihara Y, et al. Living donor liver transplantation in children with cholestatic liver disease: a single-center experience. Transplant Proc. 2012;44:469–72.

    Article  CAS  PubMed  Google Scholar 

  6. Sanada Y, Mizuta K, Urahashi T, et al. Indication of liver transplantation for jaundice-free biliary atresia with portal hypertension. Ann Transplant. 16:7–11.

  7. Tomita H, Masugi Y, Hoshino K, et al. Long-term native liver fibrosis in biliary atresia: development of a novel scoring system using histology and standard liver tests. J Hepatol. 2014;60:1242–8.

    Article  CAS  PubMed  Google Scholar 

  8. Westheim BH, Aagenæs I, Østensen AB, et al. Effect of operator experience and frequency of procedure performance on complication rate after ultrasound-guided percutaneous liver biopsies. J Pediatr Gastroenterol Nutr. 2013;57:638–43.

    Article  PubMed  Google Scholar 

  9. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–57.

    Article  PubMed  Google Scholar 

  10. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology. 1994; 20:15–20.

  11. Kamada Y, Akita M, Takeda Y, et al. Serum fucosylated haptoglobin as a novel diagnostic biomarker for predicting hepatocyte ballooning and nonalcoholic steatohepatitis. PLoS ONE. 2013;8:e66328.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Toshima T, Shirabe K, Ikegami T, et al. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis. J Gastroenterol. 2014:1–9.

  13. Umemura T, Joshita S, Sekiguchi T, et al. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. Am J Gastroenterol. 2015;110:857–64.

    Article  CAS  PubMed  Google Scholar 

  14. Sasaki R, Yamasaki K, Abiru S, et al. Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response. PLoS One. 2015;10:e0129053.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kuno A, Ikehara Y, Tanaka Y, et al. A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

    Article  CAS  PubMed  Google Scholar 

  17. Iacobelli S, Sismondi P, Giai M, et al. Prognostic value of a novel circulating serum 90 K antigen in breast cancer. Br J Cancer. 1994;69:172–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Inohara H, Akahani S, Koths K, et al. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res. 1996;56:4530–4.

    CAS  PubMed  Google Scholar 

  19. Sasaki T, Brakebusch C, Engel J, et al. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J. 1998;17:1606–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yamasaki K, Tateyama M, Abiru S, et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 2014;60:1563–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Hahn SM, Kim S, Park KI, et al. Clinical benefit of liver stiffness measurement at 3 months after Kasai hepatoportoenterostomy to predict the liver related events in biliary atresia. PLoS One. 2013;8:e80652.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wiwanitkit S, Wiwanitkit V. Connective tissue growth factor, liver stiffness and transient elastography in biliary atresia. Hepatol Res. 2013;43:917.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Sysmex Co., Hyogo, Japan, which provided all materials and strategies for examination of M2BPGi.

Author information

Authors and Affiliations

  1. Department of Transplant Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan

    Naoya Yamada, Yukihiro Sanada, Masahisa Tashiro, Yuta Hirata, Noriki Okada, Yoshiyuki Ihara, Taizen Urahashi & Koichi Mizuta

Authors
  1. Naoya Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yukihiro Sanada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masahisa Tashiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuta Hirata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Noriki Okada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshiyuki Ihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Taizen Urahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Koichi Mizuta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoya Yamada.

Ethics declarations

Conflict of interest

The authors declare that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamada, N., Sanada, Y., Tashiro, M. et al. Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia. J Gastroenterol 52, 245–252 (2017). https://doi.org/10.1007/s00535-016-1235-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-016-1235-8

Keywords

Search

Navigation